Oncosil Medical Ltd has released a press release.
1st Study in Man Increases Pancreatic Tumor Vascularity
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- First patient treated with OncoSil device in Turkiye
- First patient treated in the UK for the TRIPP-FXX study
- First Austria-based treatments utilising the OncoSil device
- Prospectus - Entitlement Offer
- Placement and Entitlement Offer to raise up to $7.1 million
Later from OncoSil Medical
- $5.3 million raised under Entitlement Offer
- Australian institution to invest $2.7 million in OSL
- Successful Treatment with OncoSil Device in Turkiye
- Appendix 4E Preliminary Financial Report
- G-BA Approval received for OncoSil Device
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical